Genotype patterns that contribute to increased risk for or protection from developing heroin addiction.
paper
Cited
Public
Unavailable
- Authors
- Nielsen, D A; Ji, F; Yuferov, V; Ho, A; Chen, A; Levran, O; Ott, J; Kreek, M J
- Year
- 2008
- Journal
- Molecular psychiatry
- PMID
- 18195715
- DOI
- 10.1038/sj.mp.4002147
- PMCID
- PMC3810149
A genome-wide association study was conducted using microarray technology to identify genes that may be associated with the vulnerability to develop heroin addiction, using DNA from 104 individual former severe heroin addicts (meeting Federal criteria for methadone maintenance) and 101 individual control subjects, all Caucasian. Using separate analyses for autosomal and X chromosomal variants, we found that the strongest associations of allele frequency with heroin addiction were with the autosomal variants rs965972, located in the Unigene cluster Hs.147755 (experiment-wise q=0.053), and rs1986513 (q=0.187). The three variants exhibiting the strongest association with heroin addiction by genotype frequency were rs1714984, located in an intron of the gene for the transcription factor myocardin (P=0.000022), rs965972 (P=0.000080) and rs1867898 (P=0.000284). One genotype pattern (AG-TT-GG) was found to be significantly associated with developing heroin addiction (odds ratio (OR)=6.25) and explained 27% of the population attributable risk for heroin addiction in this cohort. Another genotype pattern (GG-CT-GG) of these variants was found to be significantly associated with protection from developing heroin addiction (OR=0.13), and lacking this genotype pattern explained 83% of the population attributable risk for developing heroin addiction. Evidence was found for involvement of five genes in heroin addiction, the genes coding for the mu opioid receptor, the metabotropic receptors mGluR6 and mGluR8, nuclear receptor NR4A2 and cryptochrome 1 (photolyase-like). This approach has identified several new genes potentially associated with heroin addiction and has confirmed the role of OPRM1 in this disease.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2025 | β |
| Genetic Associations of Persistent Opioid Use After Surgery Point to OPRM1 but Not Other Opioid-Related Loci as the Main Driver of Opioid Use Disorder. | Annis AC et al. | β | 2025 | β |
| Scoping review of associations between cytochrome P450 3A4/5 single nucleotide polymorphisms and risk factors for fentanyl overdose. | Petrovitch D et al. | β | 2025 | β |
| Genetic Variants Linked to Opioid Addiction: A Genome-Wide Association Study. | Panday SK et al. | β | 2024 | β |
| OPRM1 Gene Polymorphism in Women with Alcohol Use Disorder. | BoroΕ A et al. | β | 2024 | β |
| Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses. | Butelman ER et al. | β | 2022 | β |
| Genetic implications in quality palliative care and preventing opioid crisis in cancer-related pain management. | Sumitani M et al. | β | 2022 | β |
| Leveraging Mann-Whitney U test on large-scale genetic variation data for analysing malaria genetic markers. | Tai KY et al. | β | 2022 | β |
| MicroRNAs in drug addiction: Current status and future perspectives. | Zhao Y et al. | β | 2022 | β |
| Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. | Gaddis N et al. | β | 2022 | β |
| Mysterious long noncoding RNAs and their relationships to human disease. | Li W et al. | β | 2022 | β |
| Pharmacogenetics of Addiction Therapy. | Graham DP et al. | β | 2022 | β |
| Risk score prediction model based on single nucleotide polymorphism for predicting malaria: a machine learning approach. | Tai KY et al. | β | 2022 | β |
| Age of onset of heaviest use of cannabis or alcohol in persons with severe opioid or cocaine use disorders. | Butelman ER et al. | β | 2021 | β |
| Epigenetic and Genetic Factors Associated With Opioid Use Disorder: Are These Relevant to African American Populations. | Blackwood CA et al. | β | 2021 | β |
| Genomic and Personalized Medicine Approaches for Substance Use Disorders (SUDs) Looking at Genome-Wide Association Studies. | Cozzoli D et al. | β | 2021 | β |
| The molecular neurobiology and neuropathology of opioid use disorder. | Blackwood CA et al. | β | 2021 | β |
| Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment. | Tolami HF et al. | β | 2020 | β |
| Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism. | Cornett EM et al. | β | 2020 | β |
| Prolonged Withdrawal from Escalated Oxycodone is Associated with Increased Expression of Glutamate Receptors in the Rat Hippocampus | Salisbury AJ et al. | β | 2020 | β |
| Prolonged Withdrawal From Escalated Oxycodone Is Associated With Increased Expression of Glutamate Receptors in the Rat Hippocampus. | Salisbury AJ et al. | β | 2020 | β |
| A review of opioid addiction genetics. | Crist RC et al. | β | 2019 | β |
| Escalated Oxycodone Self-Administration and Punishment: Differential Expression of Opioid Receptors and Immediate Early Genes in the Rat Dorsal Striatum and Prefrontal Cortex. | Blackwood CA et al. | β | 2019 | β |
| VMAT2 gene (<i>SLC18A2</i>) variants associated with a greater risk for developing opioid dependence. | Randesi M et al. | β | 2019 | β |
| Human Genetics of Addiction: New Insights and Future Directions. | Hancock DB et al. | β | 2018 | β |
| Molecular Genetics and New Medication Strategies for Opioid Addiction. | Hurd YL et al. | β | 2018 | β |
| Pharmacogenetics of Methadone Response. | Fonseca F et al. | β | 2018 | β |
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2017 | β |
| Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese. | Gao X et al. | β | 2017 | β |
| Genetic variation in the exome: Associations with alcohol and tobacco co-use. | Otto JM et al. | β | 2017 | β |
| Genome-Wide Association of Heroin Dependence in Han Chinese. | Kalsi G et al. | β | 2016 | β |
| A review of pharmacogenetic studies of substance-related disorders. | Jones JD et al. | β | 2015 | β |
| Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestry. | Levran O et al. | β | 2015 | β |
| Genetics of opiate addiction. | Reed B et al. | β | 2014 | β |
| Pharmacogenetics of addiction therapy. | Nielsen DA et al. | β | 2014 | β |
| Low frequency genetic variants in the ΞΌ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. | Clarke TK et al. | β | 2013 | β |
| Nur transcription factors in stress and addiction. | Campos-Melo D et al. | β | 2013 | β |
| Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. | Bruehl S et al. | β | 2013 | β |
| Challenging false discovery rate: a partition test based on p values in human case-control association studies. | Ott J et al. | β | 2012 | β |
| Common and specific liability to addiction: approaches to association studies of opioid addiction. | Nielsen DA et al. | β | 2012 | β |
| Emerging role of non-coding RNA in neural plasticity, cognitive function, and neuropsychiatric disorders. | Spadaro PA et al. | β | 2012 | β |
| Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. | Kreek MJ et al. | β | 2012 | β |
| The genetics of the opioid system and specific drug addictions. | Levran O et al. | β | 2012 | β |
| Therapeutic potential of metabotropic glutamate receptor modulators. | HovelsΓΈ N et al. | β | 2012 | β |
| ΞΊ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. | Butelman ER et al. | β | 2012 | β |
| Genome-wide association studies identify genetic loci related to alcohol consumption in Korean men. | Baik I et al. | β | 2011 | β |
| Haplotype block structure of the genomic region of the mu opioid receptor gene. | Levran O et al. | β | 2011 | β |
| Mining Affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers. | Michelhaugh SK et al. | β | 2011 | β |
| Multilocus association mapping using generalized ridge logistic regression. | Liu Z et al. | β | 2011 | β |
| Possible association between human blood types and opioid addiction. | Aflatoonian MR et al. | β | 2011 | β |
| Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases. | Zhou Y et al. | β | 2010 | β |
| Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. | Nielsen DA et al. | β | 2010 | β |
| Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction. | Nielsen DA et al. | β | 2010 | β |
| MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. | Lipovich L et al. | β | 2010 | β |
| Overview and historical perspective of four papers presented on research related to the endogenous opioid system. | Kreek MJ | β | 2010 | β |
| Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder. | Novak G et al. | β | 2010 | β |
| Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes. | Fonseca F et al. | β | 2010 | β |
| Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. | Yuferov V et al. | β | 2010 | β |
| A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. | Yuferov V et al. | β | 2009 | β |
| Bidirectional translational research: Progress in understanding addictive diseases. | Kreek MJ et al. | β | 2009 | β |
| Detecting disease-associated genotype patterns. | Long Q et al. | β | 2009 | β |
| Dopamine genes and nicotine dependence in treatment-seeking and community smokers. | Bergen AW et al. | β | 2009 | β |
| Endogenous opiates and behavior: 2008. | Bodnar RJ | β | 2009 | β |
| Gene expression changes following extinction testing in a heroin behavioral incubation model. | Kuntz-Melcavage KL et al. | β | 2009 | β |
| Genome-wide association study of smoking initiation and current smoking. | Vink JM et al. | β | 2009 | β |
| Mapping of partially overlapping de novo deletions across an autism susceptibility region (AUTS5) in two unrelated individuals affected by developmental delays with communication impairment. | Newbury DF et al. | β | 2009 | β |
| Opiate and cocaine addiction: from bench to clinic and back to the bench. | Kreek MJ et al. | β | 2009 | β |
| Regulation of mu opioid receptor internalization by the scaffold protein RanBPM. | Talbot JN et al. | β | 2009 | β |
| Supplementing high-density SNP microarrays for additional coverage of disease-related genes: addiction as a paradigm. | Saccone SF et al. | β | 2009 | β |
| Association of candidate genes with antisocial drug dependence in adolescents. | Corley RP et al. | β | 2008 | β |
| RanBPM is expressed in synaptic layers of the mammalian retina and binds to metabotropic glutamate receptors. | Seebahn A et al. | β | 2008 | β |